Viral Infections: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 5: | Line 5: | ||
Articles in Proteopedia concerning [[Viral Infections]] include: | Articles in Proteopedia concerning [[Viral Infections]] include: | ||
* [[Coronavirus Disease 2019 (COVID-19)]] | |||
* [[HIV]] | * [[HIV]] | ||
* [[Herpes Simplex Virus Thymidine Kinase]] | * [[Herpes Simplex Virus Thymidine Kinase]] | ||
| Line 15: | Line 16: | ||
* [[Toll-like Receptors]] | * [[Toll-like Receptors]] | ||
* [[SV40 Capsid Simplified]] | * [[SV40 Capsid Simplified]] | ||
* [[Journal:PLoS ONE:1|Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates]] | |||
*[[Journal:Acta Cryst F:S2053230X19004424|Structure of the Ebola virus nucleoprotein - RNA complex]] | |||
<br /> | <br /> | ||
| Line 26: | Line 29: | ||
<br /> | <br /> | ||
To View FDA Approved Treatments for [[Viral Infections]] See: [[Pharmaceutical_Drugs#Treatments|Treatments]] <br/> | |||
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | ||